European initiative INCATE: Phase II funding of a start-up for the development of antimicrobial proteins
The incubator INCATE (INCubator for Antibacterial Therapies in Europe) was founded by a consortium of academic institutions—including the German Center for Infection Research (DZIF)—and industrial partners to support the fight against the global problem of increasing antibiotic resistance. The goal of the non-profit partnership is to bring together academia, industry, experienced entrepreneurs and investors from across Europe and beyond to advance the development of new antibiotics and diagnostics and to support start-up companies in the field. From several start-ups initially funded by INCATE, the start-up „Invitris“ has now been selected for further funding. The Phase II funding of 250,000 euros enables "Invitris" to complete the spin-off from the Technical University of Munich and to scale up the production of antimicrobial proteins in the fight against antibiotic resistance.
For more information on INCATE and its funding of the start-up „Invitris“, click here.
